Steris | STE - Ordinary Share Capital


Steris reported $98.07M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
3M USD 521.57M 8.71M Mar/2026
Accuray USD 100K 1000 Sep/2024
Avanos Medical USD 46.67M 216.61K Mar/2026
Baxter International USD 516.45M 2.17M Mar/2026
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 2.66M Dec/2025
CONMED USD 30.97M 16K Dec/2025
Cooper Companies USD 195.11M 14K Mar/2026
Dexcom USD 385.9M 1.1M Mar/2026
Ecolab USD 282.42M 812K Mar/2026
Edwards Lifesciences USD 580.7M 0 Dec/2025
Fortive USD 305.6M 7.8M Mar/2026
Getinge SEK 136M 0 Dec/2024
Globus Medical USD 135.06M 449K Dec/2025
Haemonetics USD 46.83M 82K Dec/2025
Idexx Laboratories USD 79.24M 611K Mar/2026
Inogen USD 23K 0 Dec/2023
Insulet USD 69.26M 1.08M Mar/2026
Integra LifeSciences USD 77.82M 69K Mar/2026
Intuitive Surgical USD 355.17M 674K Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Olympus JPY 1.1B 35.42K Mar/2026
Orthofix International USD 39.83M 315K Dec/2025
Owens Minor USD 76.39M 911K Dec/2025
ResMed USD 190.83M 44.86M Mar/2026
Steris USD 98.07M 72K Mar/2026
Stryker USD 382.98M 584K Mar/2026
Tandem Diabetes Care USD 68.29M 518K Dec/2025
Teleflex USD 44.26M 70K Mar/2026
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Zimmer Biomet Holdings USD 195.5M 2.68M Mar/2026